Embody

Embody: telemedicine for weight loss with GLP-1 treatment

Embody is a telehealth care program specializing in weight management that combines GLP-1 treatment, oversight by licensed clinicians, and continuous support. The company presents itself as an alternative without insurance barriers, with transparent monthly pricing and home delivery of medication.

GLP-1 treatment and clinical approach

The program is based on weekly GLP-1 injections, with options that include GLP-1 and GIP. According to the company's information, these drugs regulate appetite by mimicking natural hormones that signal fullness and reduce food-related mental noise. The approach aims to correct metabolic signals that make it difficult to maintain weight loss after a diet. The company states that compounded medications have not been approved or evaluated by the FDA for safety, efficacy, or quality, and that a professional will determine whether they are suitable for each patient.

Admission process and follow-up

Access begins with a quick online assessment to confirm eligibility and goals. Then, the patient meets with a clinician and their care team, who develop a personalized plan based on history, lifestyle, and biology. Once treatment is approved, the prescription is sent to the pharmacy and the medication is delivered with discreet shipping. The program includes ongoing support and the possibility of scheduling unlimited appointments and messaging with the care team.

Month-by-month progression according to the company

Embody describes a typical progression over the first six months. Between month 0 and 1, many members notice changes in appetite and portions. Between month 1 and 2, snacking and emotional eating decrease. Between month 2 and 3, weight loss becomes visible on the scale and in clothing. Between month 3 and 4, the program adapts to real life, making it easier to stay on track during busy weeks or social events. Between month 4 and 6, many achieve sustained results or their goal. The company clarifies that results may vary depending on adherence to the program and clinical recommendations.

Plans, pricing, and flexibility

The catalog shows weekly GLP-1 injections starting at $79 per month and GLP-1/GIP starting at $129 per month, with free shipping and no hidden fees. Prices vary depending on the chosen plan (4, 12, 24, or 52 weeks) and do not increase if the dose changes within the same medication. The company states that the monthly price remains stable as long as no other medication is added or the plan is changed. The service is compatible with HSA/FSA and allows pausing or adjusting the plan at any time. Cancellation can be made before the next shipment to avoid charges.

Support and additional services

The program includes 24/7 access to a team of specialists, unlimited appointments, and unrestricted messaging. It also offers an optional, free care coaching service, with educators who provide motivation and support, without being clinicians. The company accepts transfers of patients already receiving GLP-1 from another provider, subject to review of the current prescription to continue with the same dose if appropriate. It is possible to enroll in more than one treatment program, completing additional forms as needed.

Operations and coverage

Embody operates through its online platform and ships medication to the registered address. The company collaborates with state-licensed 503A compounding pharmacies and with OpenLoop Health, a network of US-licensed doctors that applies safety protocols and exclusion criteria to determine eligibility. The corporate headquarters is located in Wilmington, Delaware.

Location and contact

1811 Silverside Road, Suite 260, Wilmington, New Castle County, Delaware 19180 · Phone: (347) 269-4270 · Email: support@joinem.co